Harmony Biosciences Holdings Inc. Stock Price, News, Quote & History

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.

Harmony Biosciences Holdings Inc.

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome

Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress

Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference

5 US Longevity and Anti-aging Stocks to Watch in 2025

Top 5 Small-cap Biotech Stocks of 2025

Latest News

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference

Questcorp Mining Closes First Tranche of Private Placement

First Pass Scout Drilling Returns 10.5m @ 1.02% Copper at Phoenix

HIVE Digital Technologies Surpasses 22 EH/s and Accelerates Conversion from Tier-1 to Tier-3 Data Centers for AI Cloud Expansion in Sweden

Hispania Resources Announces Update to Proposed Private Placement

Latest News

Outlook Reports world

Featured Biotech Investing Stocks

Browse Companies